| Stage | JBI | % of rev | LGIH | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $234M | 100.00% | $516M | 100.00% | LGIH ×2.21 |
| Gross profit | $80M | 34.39% | $102M | 19.71% | JBI +14.7pp |
| Operating income | $21M | 8.82% | $29M | 5.61% | JBI +3.2pp |
| Pre-tax income | $13M | 5.61% | $37M | 7.09% | LGIH +1.5pp |
| Net income | $11M | 4.58% | $27M | 5.23% | LGIH +0.6pp |
| Stage | JBI | LGIH | Gap · A − B |
|---|---|---|---|
| Revenue | $234M100.00% | $516M100.00% | LGIH ×2.21 |
| Gross profit | 34.39%$80M | 19.71%$102M | JBI +14.7pp |
| Operating income | 8.82%$21M | 5.61%$29M | JBI +3.2pp |
| Pre-tax income | 5.61%$13M | 7.09%$37M | LGIH +1.5pp |
None
No disclosed counterparties: JBI.
| Net income |
| 4.58%$11M |
| 5.23%$27M |
| LGIH +0.6pp |